×

CellRapeutics™ Serum from Cytomegalovirus Donor (XS-0426-XU64)

Online Inquiry  Datasheet

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

This serum is collected from donors with serological evidence of CMV exposure. It features a high titer of anti-CMV IgG or IgM antibodies and a unique secretome associated with viral latency or reactivation. It is an essential reagent for validating diagnostic assays and studying the impact of chronic viral carriage on "inflammaging" and T-cell repertoire exhaustion.

Specific Inquiry

  • Size:
  Add to Cart

Donor Information

  • Product Name
  • CellRapeutics™ Serum from Cytomegalovirus Donor
  • Cat. No.
  • XS-0426-XU64
  • Donor Age
  • Young Adult, Middle-Aged
  • Donor Health
  • Confirmed seropositive for Cytomegalovirus. Serum contains specific anti-CMV immunoglobulins, reflecting a state of latent infection or historical immune response to this herpesvirus.
  • Ethnicity
  • Diverse backgrounds available.
  • Anticoagulant
  • None (separated via centrifugation following natural coagulation).
  • Additional Donor Information
  • Each lot features serum from CMV-seropositive donors. Profiles include CMV-specific IgG and IgM titers, and differentiation between latent infection and recent primary infection or reactivation.
  • Clinical Profile
  • CMV IgG/IgM status, viral load, and history of CMV-related complications.

Additional Information

  • Medication History
  • Available upon request. Documentation of CMV serostatus and any history of antiviral therapy for active infection.
  • Formulation
  • Frozen
  • Cell Viability
  • Cell-free (no residual erythrocytes or leukocytes).
  • Mycoplasma Testing
  • Negative
  • Sterility Testing
  • Negative
  • Application
  • Drug Discovery, Immuno-oncology Research
  • Research Use Only
  • RUO
  • Quality Control
  • Each serum batch undergoes rigorous IRB-compliant screening, ensuring pathogen-free safety, consistent physicochemical properties, and standardized clinical characterization of disease-specific biomarkers to provide a reliable, high-purity biological matrix.
  • Storage
  • Store at -80°C or below for long-term stability, or at -20°C for up to 6 months, avoid repeated freeze-thaw cycles to preserve product quality.
  • Shiping
  • Dry Ice
  • Handling Notes
  • Thaw slowly on ice or at 4°C and centrifuge to remove cryoprecipitates, immediate aliquoting upon first thaw is recommended to maintain autoantibody functional integrity.
  • Warnings
  • Treat as potentially biohazardous human-derived material and handle strictly under BSL-2 guidelines using appropriate personal protective equipment.
  • Size
  • 1ML
  • Keywords
  • CellRapeutics™ Serum from Cytomegalovirus Donor, Serum, Cytomegalovirus

Case Studies

Customer Reviews and Q&As

There are currently no customer reviews or questions for CellRapeutics™ Serum from Cytomegalovirus Donor (XS-0426-XU64). Click the button below to contact us or submit your feedback about this product.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Related Products

Immune Cell Products

T Cell Products

B Cell Products

Mouse Cell Products

PBMC Products

Dendritic Cell Products

Stem Cell Products

Online Inquiry
Products
Global Services. (Creative Biolabs Authorized)
Online Inquiry

For any technical issues or product/service related questions, please leave your information below. Our team will contact you soon.

Key Updates
Newsletter. (Creative Biolabs Authorized) NEWSLETTER

The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders

LEARN MORE NEWSLETTER
New Solution. (Creative Biolabs Authorized) NEW SOLUTION

CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.

LEARN MORE SOLUTION
Novel Solution. (Creative Biolabs Authorized) NOVEL TECHNOLOGY

Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.

LEARN MORE NOVEL TECHNOLOGY
New Technology. (Creative Biolabs Authorized) NEW SOLUTION

Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.

LEARN MORE SOLUTION
Receive our latest news and insights.
Copyright © 2026 Creative Biolabs. All Rights Reserved
  • 0
  • 0
Cart
    Go to checkout